Ye Zhang-Qun, Zeng Xiao-Yong
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
Zhonghua Nan Ke Xue. 2003 Oct;9(7):483-8.
So far the etiology of chronic prostatitis(CP), particularly chronic nonbacterial prostatitis(NBP) or chronic pelvic pain syndrome (CPPS), remains to be elucidated. According to recent epidemiologic data, the prevalence of CP ranged from 2.5% to 16% of the world population, affecting men of all ages and all ethnic origins. Since 1990s researchers of many countries have carried out largerscaled, deeper and more extensive studies than ever before on the etiology, diagnosis and treatment of the disease, with the sponsorship and coordination of such international institutions as the International Prostatitis Collaborative Network(IPCN), the Chronic Prostatitis Collaborative Research Network of the National Institute of Health (NIH-CPCRN) and so on. The main achievements of recent years include: the etiology of CP/CPPS being a complicated multi-step and multi-factor course, the establishment of the new clinical classification system, the introduction of the National Institute of Health chronic prostatitis symptom index, the new criteria of diagnosis and standardized clinical evaluation, the primary explorations of new treatment methods and medicines, etc. Further investigations suggested are the optimization of clinical classification, the screening and verification of treatment methods and medicines for CP/CPPS, etc.
到目前为止，慢性前列腺炎（CP），尤其是慢性非细菌性前列腺炎（NBP）或慢性盆腔疼痛综合征（CPPS）的病因仍有待阐明。根据最近的流行病学数据，CP在世界人口中的患病率为2.5%至16%，影响所有年龄段和所有种族的男性。自20世纪90年代以来，许多国家的研究人员在国际前列腺炎协作网络（IPCN）、美国国立卫生研究院慢性前列腺炎协作研究网络（NIH-CPCRN）等国际机构的赞助和协调下，对该疾病的病因、诊断和治疗进行了比以往更大规模、更深入、更广泛的研究。近年来的主要成果包括：CP/CPPS的病因是一个复杂的多步骤、多因素过程，新临床分类系统的建立，美国国立卫生研究院慢性前列腺炎症状指数的引入，新的诊断标准和标准化临床评估，新治疗方法和药物的初步探索等。建议进一步研究的是优化临床分类，筛选和验证CP/CPPS的治疗方法和药物等。
